Insulin rescues amyloid β-induced impairment of hippocampal long-term potentiation

Neurobiology of Aging

Volumn 30, Issue 3, 2009, Pages 377-387

  Lee, Cheng Che ^a   Kuo, Yu Min ^a   Huang, Chiung Chun ^a   Hsu, Kuei Sen ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; Amyloid ; Hemoglobin; Hippocampus; Insulin; Long term potentiation

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; DIMER; DITHIOTHREITOL; HEMOGLOBIN; INSULIN; OLIGOMER; SOMATOMEDIN C;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SYNAPSE; TISSUE SLICE;

AMYLOID BETA-PEPTIDES; ANIMALS; HIPPOCAMPUS; INSULIN; LONG-TERM POTENTIATION; MALE; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 58549102356     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.06.014     Document Type: Article

References (63)

1. Aguado-Llera D., Arilla-Ferreiro E., Campos-Barros A., Puebla-Jimenez L., and Barrios V. Protective effects of insulin-like growth factor-I on the somatostatinergic system in the temporal cortex of β-amyloid-treated rats. J. Neurochem. 92 3 (2005) 607-615
2. Alvarez A., Toro R., Caceres A., and Maccioni R.B. Inhibition of tau phosphorylating protein kinase cdk5 prevents β-amyloid-induced neuronal death. FEBS Lett. 459 3 (1999) 421-426
3. Banks W.A., Jaspan J.B., Huang W., and Kastin A.J. Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides 18 9 (1997) 1423-1429
4. Beattie E.C., Carroll R.C., Yu X., Morishita W., Yasuda H., von Zastrow M., and Malenka R.C. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat. Neurosci. 3 12 (2000) 1291-1300
5. 42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. U.S.A. 100 1 (2003) 330-335
6. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V., Hyman B.T., Younkin S.G., and Hsiao K.K. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2 3 (1999) 271-276
7. Chen Q.S., Kagan B.L., Hirakura Y., and Xie C.W. Impairment of hippocampal long-term potentiation by Alzheimer amyloid β-peptides. J. Neurosci. Res. 60 1 (2000) 65-72
8. Craft S., Peskind E., Schwartz M.W., Schellenberg G.D., Raskind M., and Porte Jr. D. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 50 1 (1998) 164-168
9. Ferrer I., Boada Rovira M., Sanchez Guerra M.L., Rey M.J., and Costa-Jussa F. Neuropathology and pathogenesis of encephalitis following amyloid-β immunization in Alzheimer's disease. Brain Pathol. 14 1 (2004) 11-20
10. 1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo. J. Neurophysiol. 89 6 (2003) 2917-2922
11. Freir D.B., Holscher C., and Herron C.E. Blockade of long-term potentiation by β-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J. Neurophysiol. 85 2 (2001) 708-713
12. Gasparini L., Gouras G.K., Wang R., Gross R.S., Beal M.F., Greengard P., and Xu H. Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and requires mitogen-activated protein kinase signaling. J. Neurosci. 21 8 (2001) 2561-2570
13. Gasparini L., Netzer W.J., Greengard P., and Xu H. Does insulin dysfunction play a role in Alzheimer's disease?. Trends Pharmacol. Sci. 23 6 (2002) 288-293
14. Gasparini L., and Xu H. Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci. 26 8 (2003) 404-406
15. Gengler S., Gault V.A., Harriott P., and Holscher C. Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25-35) are dependent on stimulation-protocol and genetic background. Exp. Brain Res. 179 4 (2007) 621-630
16. Glenner G.G., and Wong C.W. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122 3 (1984) 1131-1135
17. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.C., Zaidi M.S., and Wisniewski H.M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261 13 (1986) 6084-6089
18. Hensley K., Floyd R.A., Zheng N.Y., Nael R., Robinson K.A., Nguyen X., Pye Q.N., Stewart C.A., Geddes J., Markesbery W.R., Patel E., Johnson G.V., and Bing G. p38 kinase is activated in the Alzheimer's disease brain. J. Neurochem. 72 5 (1999) 2053-2058
19. Hill J.M., Lesniak M.A., Pert C.B., and Roth J. Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas. Neuroscience 17 4 (1986) 1127-1138
20. Huang C.C., Liang Y.C., and Hsu K.S. A role for extracellular adenosine in time-dependent reversal of long-term potentiation by low-frequency stimulation at hippocampal CA1 synapses. J. Neurosci. 19 22 (1999) 9728-9738
21. Huang C.C., Lee C.C., and Hsu K.S. An investigation into signal transduction mechanisms involved in insulin-induced long-term depression in the CA1 region of the hippocampus. J. Neurochem. 89 1 (2004) 217-231
22. Huang C.C., and Hsu K.S. Sustained activation of metabotropic glutamate receptor 5 and protein tyrosine phosphatases mediate the expression of (S)-3,5-dihydroxyphenylglycine-induced long-term depression in the hippocampal CA1 region. J. Neurochem. 96 1 (2006) 179-194
23. Jacobsen J.S., Reinhart P., and Pangalos M.N. Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer's disease. NeuroRx 2 4 (2005) 612-626
24. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 5618 (2003) 486-489
25. Klyubin I., Walsh D.M., Lemere C.A., Cullen W.K., Shankar G.M., Betts V., Spooner E.T., Jiang L., Anwyl R., Selkoe D.J., and Rowan M.J. Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo. Nat. Med. 11 5 (2005) 556-561
26. Kurochkin I.V. Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme. FEBS Lett. 427 2 (1998) 153-156
27. LaFerla F.M., and Oddo S. Alzheimer's disease: Aβ, tau and synaptic dysfunction. Trends Mol. Med. 11 4 (2005) 170-176
28. 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 95 11 (1998) 6448-6453
29. Lee M.S., Kwon Y.T., Li M., Peng J., Friedlander R.M., and Tsai L.H. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405 6784 (2000) 360-364
30. Leibson C.L., Rocca W.A., Hanson V.A., Cha R., Kokmen E., O'Brien P.C., and Palumbo P.J. The risk of dementia among persons with diabetes mellitus: a population-based cohort study. Ann. N. Y. Acad. Sci. 826 (1997) 422-427
31. LeVine III H. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2 3 (1993) 404-410
32. Lin J.W., Ju W., Foster K., Lee S.H., Ahmadian G., Wyszynski M., Wang Y.T., and Sheng M. Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization. Nat. Neurosci. 3 12 (2000) 1282-1290
33. Liu R., McAllister C., Lyubchenko Y., and Sierks M.R. Residues 17-20 and 30-35 of β-amyloid play critical roles in aggregation. J. Neurosci. Res. 75 2 (2004) 162-171
34. Man H.Y., Lin J.W., Ju W.H., Ahmadian G., Liu L., Becker L.E., Sheng M., and Wang Y.T. Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization. Neuron 25 3 (2000) 649-662
35. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., and Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 82 12 (1985) 4245-4249
36. McDonald D.R., Bamberger M.E., Combs C.K., and Landreth G.E. β-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J. Neurosci. 18 12 (1998) 4451-4460
37. Nalbantoglu J., Tirado-Santiago G., Lahsaini A., Poirier J., Goncalves O., Verge G., Momoli F., Welner S.A., Massicotte G., Julien J.P., and Shapiro M.L. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 387 6632 (1997) 500-505
38. Nicoll J.A., Wilkinson D., Holmes C., Steart P., Markham H., and Weller R.O. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat. Med. 9 4 (2003) 448-452
39. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., and Breteler M.M. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53 9 (1999) 1937-1942
40. Pike C.J., Walencewicz-Wasserman A.J., Kosmoski J., Cribbs D.H., Glabe C.G., and Cotman C.W. Structure-activity analyses of β-amyloid peptides: contributions of the β 25-35 region to aggregation and neurotoxicity. J. Neurochem. 64 1 (1995) 253-265
41. Plum L., Schubert M., and Bruning J.C. The role of insulin receptor signaling in the brain. Trends Endocrinol. Metab. 16 2 (2005) 59-65
42. Poduslo J.F., Curran G.L., and Berg C.T. Macromolecular permeability across the blood-nerve and blood-brain barriers. Proc. Natl. Acad. Sci. U.S.A. 91 12 (1994) 5705-5709
43. Qiu W.Q., and Folstein M.F. Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis. Neurobiol. Aging 27 2 (2006) 190-198
44. Qureshi S.A., Ding V., Li Z., Szalkowski D., Biazzo-Ashnault D.E., Xie D., Saperstein R., Brady E., Huskey S., Shen X., Liu K., Xu L., Salituro G.M., Heck J.V., Moller D.E., Jones A.B., and Zhang B.B. Activation of insulin signal transduction pathway and anti-diabetic activity of small molecule insulin receptor activators. J. Biol. Chem. 275 47 (2000) 36590-36595
45. Rensink A.A., Otte-Holler I., de Boer R., Bosch R.R., ten Donkelaar H.J., de Waal R.M., Verbeek M.M., and Kremer B. Insulin inhibits amyloid β-induced cell death in cultured human brain pericytes. Neurobiol. Aging 25 1 (2004) 93-103
46. Reger M.A., Watson G.S., Frey II W.H., Baker L.D., Cholerton B., Keeling M.L., Belongia D.A., Fishel M.A., Plymate S.R., Schellenberg G.D., Cherrier M.M., and Craft S. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol. Aging 27 3 (2006) 451-458
47. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., and Seubert P. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 6740 (1999) 173-177
48. Selkoe D.J. Clearing the brain's amyloid cobwebs. Neuron 32 2 (2001) 177-180
49. Selkoe D.J., and Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 545-584
50. Shoji M., Iwakami N., Takeuchi S., Waragai M., Suzuki M., Kanazawa I., Lippa C.F., Ono S., and Okazawa H. JNK activation is associated with intracellular β-amyloid accumulation. Brain Res. Mol. Brain Res. 85 1-2 (2000) 221-233
51. 22-35) on the hippocampal neuron and its prevention. Neurosci. Lett. 161 1 (1993) 41-44
52. Townsend M., Shankar G.M., Mehta T., Walsh D.M., and Selkoe D.J. Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol. 572 2 (2006) 477-492
53. Troy C.M., Rabacchi S.A., Xu Z., Maroney A.C., Connors T.J., Shelanski M.L., and Greene L.A. β-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation. J. Neurochem. 77 1 (2001) 157-164
54. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 6880 (2002) 535-539
55. Walsh D.M., Lomakin A., Benedek G.B., Condron M.M., and Teplow D.B. Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem. 272 35 (1997) 22364-22372
56. Walsh D.M., Townsend M., Podlisny M.B., Shankar G.M., Fadeeva J.V., Agnaf O.E., Hartley D.M., and Selkoe D.J. Certain inhibitors of synthetic amyloid β-peptide (Aβ) fibrillogenesis block oligomerization of natural Aβ and thereby rescue long-term potentiation. J. Neurosci. 25 10 (2005) 2455-2462
57. Wang Q., Walsh D.M., Rowan M.J., Selkoe D.J., and Anwyl R. Block of long-term potentiation by naturally secreted and synthetic amyloid β-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci. 24 13 (2004) 3370-3378
58. Wickelgren I. Tracking insulin to the mind. Science 280 5363 (1998) 517-519
59. Wozniak M., Rydzewski B., Baker S.P., and Raizada M.K. The cellular and physiological actions of insulin in the central nervous system. Neurochem. Int. 22 1 (1993) 1-10
60. Wu C.W., Liao P.C., Yu L., Wang S.T., Chen S.T., Wu C.M., and Kuo Y.M. Hemoglobin promotes Aβ oligomer formation and localizes in neurons and amyloid deposits. Neurobiol. Dis. 17 3 (2004) 367-377
61. Xie L., Helmerhorst E., Taddei K., Plewright B., Van Bronswijk W., and Martins R. Alzheimer's β-amyloid peptides compete for insulin binding to the insulin receptor. J. Neurosci. 22 10 (2002) RC221
62. Zhang B., Salituro G., Szalkowski D., Li Z., Zhang Y., Royo I., Vilella D., Diez M.T., Pelaez F., Ruby C., Kendall R.L., Mao X., Griffin P., Calaycay J., Zierath J.R., Heck J.V., Smith R.G., and Moller D.E. Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science 284 5416 (1999) 974-977
63. Zhu X., Raina A.K., Rottkamp C.A., Aliev G., Perry G., Boux H., and Smith M.A. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem. 76 2 (2001) 435-441